Hormone treatment plus radiation delays growth of prostate cancer
AUTOR(ES)
Tanne, Janice Hopkins
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2190269Documentos Relacionados
- Clodronate for treatment of bone metastases in hormone refractory prostate cancer
- Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer
- Radiation for prostate cancer increases risk of rectal cancer
- Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
- Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.